post

PODCAST: Vancomycin by Continuous Infusion

A few weeks ago I posted on Vancomycin and the Nephrocidal Maniacs – in that post I described the problems that we have in the Kimberley with MRSA, renal disease and sepsis.  We walk a fine line between toxicity and efficacy when we treat our patients with severe, limb-threatening infections. I have learned a lot […]

post

Old Doc, New Data: Mild asthma strategies

Mild asthma is a disease that every GP manages most days. We are guided by our National Asthma Council recommendations in the treatment of simple, mild asthma. For many patients, the use of intermittent short-acting bronchodilators is the easiest and usually an adequate strategy. Some patients with more frequent symptoms will require some form of […]

post

I: Vancomycin & the Nephrocidal Maniacs

Vancomycin was first isolated in 1953 by Edmund Kornfeld from a soil sample collected from the jungles of Borneo by a missionary. It is produced by the soil bacterium Amycolatopsis orientalis. It was first licensed for use in patients with penicillin resistant Staph infections in 1958. Yes, vancomycin has been around longer than the Beatles! […]

post

CREDENCE Trial PODCAST: Can-I-get-a-flozin?

The CREDENCE trial was published in the NEJM last month and it has made some waves in the world of diabetes management. The headlines state that this SGLT2 drug can reduce the progression of diabetic nephropathy. That is big news indeed. So, what do I think about this new data for a drug that had […]

post

First10EM Journal Club: February 2019

Welcome to another edition of the Broomedocs/ First10EM podcast. This month Justin and I serve up a selection of serious and seriously unusual papers. Key learning points: sharks are safe, The NEJM is dangerous and you just may be able to outrun Death. As always – the links to the full text PDFs and into […]